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Abstract 
 
 Insomnia and Obstructive Sleep Apnoea Hypopnea Syndrome (OSAHS) are the 
two most common sleep disorders, and both have significant associated health costs.  
Despite this, relatively little is known about the prevalence or impact of Insomnia in those 
with OSAHS, although a recent suggested there may be substantial comorbidity between 
these disorders [1].  The primary aim of this study was to further explore the prevalence of 
Insomnia in OSAHS.  A secondary aim was to assess the effect of factors that may impact 
on both conditions, including mood and sleep-beliefs.  Consecutive patients referred to an 
accredited Sleep Investigations Unit (n = 105) completed a brief standardized battery of 
validated questionnaires assessing sleep-related variables and mood.  Results showed a 
high rate of prevalence of clinical Insomnia in this OSAHS population, and a strong 
positive correlation between OSAHS and insomnia symptom severity.  Further, OSAHS 
patients with comorbid Insomnia had increased levels of depression, anxiety and stress 
compared to patients with OSAHS-only, and both patient groups reported similar and 
significant levels of dysfunctional beliefs about sleep.  Findings in relation to habitual 
sleep, assessed using subjective (diary) and objective criteria (PSG), were mixed but 
generally showed greater sleep disturbance among those with OSAHS-plus compared to 
those with OSAHS-only.  Overall these findings suggest that comorbidity of Insomnia in 
OSAHS patients may lead to increased OSAHS severity and that patients with both 
conditions may experience more symptoms relating to depression, anxiety and stress.  
These findings underscore the need for insomnia assessment and management services, 
even in clinics that primarily service patients with OSAHS. 
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Introduction 
Obstructive Sleep Apnoea Hypopnea Syndrome (OSAHS) and Insomnia are the 
two most common sleep disorders [2,3], yet the co-occurrence and potential for interaction 
between OSAHS and Insomnia has rarely been examined.  Findings from preliminary 
studies suggest there may be a comorbid relationship between these two disorders [1].  
Indeed, a relationship between insomnia and OSAHS has been demonstrated previously in 
a range of samples including the elderly [4], patients with Post-Traumatic Stress Disorder 
[5], and those seeking treatment for sleep problems in primary care [6] and sleep clinic 
settings [1,7].   
Estimates of percentage of OSAHS patients who also have insomnia range from 
8% (primary care sample [6]) to between 29 and 43% (older adults [4]).  Of particular 
relevance to this study however, is the finding that between 25 and 50% of sleep clinic 
clients referred for investigation of OSAHS have been found to have comorbid insomnia [1, 
7].  The finding that as many as one in two OSAHS patients seen at sleep clinics may have 
concurrent insomnia suggests there may be a significant relationship between OSAHS and 
Insomnia, however specific limitations of past research need to be addressed before the 
nature of this relationship can be more clearly understood.  
A limitation of the two OSAHS-insomnia studies conducted previously in sleep 
clinic settings relates to the assessment and diagnosis of insomnia.  For example, although 
Krakow et al. found that 50% of patients presenting for investigation of sleep-disordered 
breathing exhibited significant Insomnia symptoms, a three-item scale only was used to 
diagnose Insomnia [1].  This scale is not a well-established tool for the assessment of 
insomnia.  In the study by Sahai, Staats and Olsen [7],  24 out of 99 patients diagnosed with 
OSAHS via PSG were found to have clinically significant Insomnia on the basis of case 
note review.  However, the Sahai et al. study [7] was retrospective and may have been 
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limited by the quality or variability of data recorded in patient files, particularly in relation 
to the assessment of insomnia.  In both studies, the use of unpublished or unvalidated 
Insomnia assessment tools may have resulted in over- or under-inflation of Insomnia 
prevalence estimates.  Finally, it should be noted that although both previous studies used 
conventional criteria (ie. PSG data) to assess OSAHS, the assessment of OSAHS in these 
studies could have have been improved by the inclusion of other standardised measures of 
OSAHS symptoms to assess the subjective severity of the apnea complaint. 
Diagnoses of insomnia and OSAHS rely to varying extents on subjective reports of 
sleep disturbance. However, variables that have been shown to impact on subjective sleep 
complaints have not typically been assessed in previous insomnia-OSAHS studies.  That is, 
measures of depression, anxiety and dysfunctional sleep-related cognitions have been 
shown to be more predictive of subjective sleep complaints than are objective measures of 
disturbance [8].   The inclusion of measures to assess variables such as depression may shed 
further light on the nature of the relationship between these two disorders, and would 
expand previous research in this area.  In general, it would seem reasonable to expect 
patients with OSAHS and insomnia may report more impairment than those with OSAHS-
only, given that previous research has shown that Insomnia and OSAHS share some 
characteristics such as sleep disruption and decreased mood [9-11], and that factors thought 
to perpetuate and maintain insomnia include poor sleep habits and dysfunctional sleep 
beliefs [12].   
The primary aim of the current study was to investigate the prevalence of 
significant Insomnia in a consecutive series of patients presenting to a tertiary care setting 
for investigation of suspected OSAHS, and to do so in a manner that addressed a specific 
weakness identified in previous OSAHS-insomnia research (specifically, the failure to use 
standardized Insomnia assessment tools; the failure to include comprehensive assessment 
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of OSAHS symptoms).  Thus, the first hypothesis for this study was that a high proportion 
of patients with diagnosed OSAHS would report significant Insomnia.  The second aim of 
this study was to explore the implications of OSAHS-insomnia comorbidity on factors 
known to affect subjective reports of sleep quality (ie. mood and sleep cognition) and sleep 
behaviour.  Specifically, it was expected that having insomnia plus OSAHS would result in 
more adverse health effects than having OSAHS alone. 
Method 
Participants 
 Participants were consecutive adult patients referred by their general practitioner 
for investigation of OSAHS at a Sleep Investigations Unit.  One hundred and five patients 
were included in the sample (73 males, mean age = 53.91 +/- 13.67 years [range: 18 to 
87]).  The mean length of sleep disturbance in this sample was 11.97 +/- 10.99 years.  
Participants did not receive compensation for their participation.     
 
Materials 
Measures used in this study were primarily selected to assess signs and symptoms 
of Insomnia and OSAHS.  Participants completed a battery of four questionnaires 
(presented in a latin squares design to reduce order effects) and a sleep diary (the 
Pittsburgh Sleep Diary (PghSD)) which was completed over two-weeks.  The 
questionnaires included in the battery were: the Survey Screen for the Prediction of Apnea 
(SSPA), the Insomnia Severity Index (ISI), Depression Anxiety and Stress Scales (DASS) 
and the Dysfunctional Beliefs and Attitudes Scale (DBAS-10).  All participants went on to 
PSG diagnostic study and data on objective sleep parameters were extracted from 
consenting patient’s hospital charts.  Several of the measures used in this study yield total 
and subscale scores (e.g. SSPA, DASS, DBAS) and in most instances both score types 
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were used in statistical analysis unless otherwise stated.  A brief description of each 
measure including subscale scores follows. 
Survey Screen for the Prediction of Apnea (SSPA).  The Survey Screen for the Prediction 
of Apnea (SSPA [13]) is a 13-item questionnaire examining the symptoms of OSAHS.  
Items are rated on a six-point Likert scale as frequency of occurrence ranging from never 
(score of zero) to five to seven times per week (score of four), with a don’t know response 
scored as five.  The SSPA contains four subscales labelled apnea symptom frequency 
(three items), difficulty sleeping (five items), excessive daytime sleepiness (three items), 
and narcolepsy symptoms (two items).  The reliability of the SSPA has been investigated 
previously [13] and found to be adequate.   
Dysfunctional Beliefs and Attitudes About Sleep Scale-10 (DBAS –10).  The short version 
of Morin’s Dysfunctional Beliefs and Attitudes about Sleep Scale (DBAS) [11], the DBAS-
10 [14], was used in this study.  The DBAS-10 is a 10-item analog scaled questionnaire that 
focuses on respondent’s personal rating of statements of beliefs and attitudes about sleep.  
It measures five subscales: misconceptions of the causes of insomnia; misattributions or 
amplifications of the consequences of insomnia; unrealistic sleep expectations; diminished 
perceptions of control and faulty beliefs about sleep-promoting practices [11]. The DBAS-
10 comprises of three factors [14]; beliefs about the immediate negative consequences of 
insomnia (five items); beliefs about the long-term negative consequences of insomnia 
(three items) and beliefs about the need for control over insomnia (two items).  Response 
options range from strongly disagree to strongly agree with respondents asked to place a 
mark along the ten centimeter line to indicate the extent of agreement with given 
statements.  For the three factors, higher scores indicate increased dysfunctional beliefs and 
attitudes about sleep.  Adequate reliability has been reported for the three DBAS-10 factors 
[14], and the validity of factors has been demonstrated previously (i.e., DBAS-10 factor 
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scores are sensitive to treatment effects and are highly correlated with the DBAS total 
score [14]).   
Insomnia Severity Index (ISI). The Insomnia Severity Index (ISI1; [11]) is a self-report 
questionnaire measuring a time interval of two weeks.  Consisting of seven items 
measuring patients’ perceptions of their Insomnia, participants’ rate ISI items on a scale of 
not at all (score of zero) to very much (score of four).  ISI items correspond generally to 
diagnostic criteria of significant Insomnia according to the DSM-IV.  These include the 
severity of sleep onset, sleep maintenance and early morning awakenings, satisfaction with 
the current sleep patterns, interference with daily functioning, noticability of sleep 
impairment and the degree of worry or distress [15].  Scores range from 0 to 28, with higher 
scores indicating more severe insomnia.  Morin [11] recommends that scores ranging from 
zero to seven be classified as no clinically significant Insomnia, eight to 14 as subthreshold 
Insomnia, 15 to 21 as moderate clinical Insomnia and 22 to 28 as severe clinical Insomnia.  
The psychometric properties of the ISI (reliability and validity) have been investigated 
previously and found to be adequate [15].   
Five additional items originating from an earlier version of the ISI were added to 
the index for this study.  Four of the items ask respondents to indicate, on a scale of not at 
all (zero) to very much (four), the extent to which participants believe racing thoughts, 
muscle tension / pain, bad sleep habits and natural aging processes affect their sleep.  
These questions were included to assess factors that patients may identify as the cause of 
their sleep problem.   
The last additional ISI item asks the respondent to circle statements that best apply 
to the problems experienced after a poor night’s sleep.  Four categories including 
statements concerning fatigue and sleepiness, cognitive functioning, mood problems and 
                                                 
1 The ISI was originally known as the Sleep Impairment Index (SII [12]). 
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physical problems are presented for the patient to circle.  This item ascertains the daytime 
consequences of the patients sleep problem.  The five additional items were not included in 
the ISI total score. 
Depression Anxiety Stress Scale-21 (DASS - 21).  The Depression Anxiety Stress Scales 
(DASS [16]) consists of 21-items measuring the three negative emotional states of 
depression (seven items), anxiety (seven items) and stress (seven items).  The DASS-21 
was included in this study to provide a screening assessment of the level of 
psychopathology among participants, as an indicator of the mental health of participants.  
Using a four-point Likert scale respondents are required to rate the frequency of DASS-21 
symptoms over a time frame of the last week.  The DASS yields a total score as well as 
separate indices of depression, anxiety, and depression and has been normed on an 
Australian sample.  The psychometric properties (reliability and validity) of the DASS-21 
total scores and subscales have been investigated previously and are considered adequate 
[16, 17]. 
The Pittsburgh Sleep Diary (PghSD). The Pittsburgh Sleep Diary (PghSD [18]) is a 24-item 
diary measuring the subjective patterns of sleep.  The PghSD comprises two components 
relating to waketime and bedtime behaviours.  The format of the diary contains items 
measured on five-point Likert scale, visual analogue scale or fill-in-the-blanks format.  
Respondents are required to fill out the sleep diary for 14 consecutive days each morning 
and night.  The bedtime component of the diary assesses four areas including the timing of 
breakfast, lunch and dinner; the consumption of caffeine, alcohol and tobacco; the use of 
medications and the timing and duration of exercise and naps.  The waketime component 
of the diary assesses four areas including the timing of bed, turning out of lights, sleep 
onset latency and awakening; the method of final waking; the incidence, duration and 
reasons for wake after sleep onset and sleep quality, mood on final awakening and 
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alertness on awakening.  The PghSD has adequate test-retest reliability, is sensitive to 
differences in sleep patterns due to age, gender, weekends, personality and circadian type, 
and yields moderate stable correlations with PSG measures of sleep [18].    
Procedure 
 Patients were invited to participate in the study by their Sleep Physician during 
routine clinical appointments.  The questionnaire battery included a patient information 
sheet detailing the study and their involvement along with a consent form requiring the 
patient signature confirming voluntary involvement in the study.  The questionnaire battery 
was given to the patients who agreed to take part in the study and was completed on site.  
The sleep diary was taken home to complete and returned to the hospital via return-paid 
mail.  With the participants’ consent, information regarding respiratory disturbance index 
(RDI; a measure of OSAHS severity), sleep efficacy (%), and age was then obtained from 
their hospital charts.   
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Results 
Data Analysis Review 
The data analysis for this project was conducted using SPSS for windows (version 
11) statistical software.  A small amount of missing data on age and RDI variables (n = 1 
and n = 5 respectively) was replaced with the series mean in accordance with procedures 
described in Tabachnick and Fidell [19].  All tests of statistical significance were calculated 
at the alpha level of 0.05.  Effect sizes between groups were calculated with eta squared 
(ŋ²) or Cramėr’s V.  
Prevalence of Insomnia in OSAHS patients  
To examine the prevalence of significant Insomnia in patients with OSAHS, data 
was sorted by selecting those patients that met the research criteria for significant 
Insomnia.  The criteria for Insomnia included 1) an ISI score of 15 or more (corresponding 
to moderate Insomnia) 2) length of sleep complaint longer than 6 months 3) SOL or 
WASO longer than 30 minutes on PSG and 4) at least one negative daytime consequence 
of sleep disturbance. The criterion for the diagnosis of OSAHS was derived from PSG data 
and review by a sleep physician, reflecting routine clinical practice at the study site.  There 
were three patients who did not subsequently receive a diagnosis of OSAHS and data from 
these participants was therefore excluded from subsequent between group analyses.  A 
frequency table was produced to assess the number of patients who had significant 
Insomnia out of the OSAHS patient group.  As expected there was a high prevalence of 
Insomnia in OSAHS patients, with 41 (39%) of the OSAHS patients having significant 
Insomnia according to the research criteria.   
Impact of comorbid OSAHS and Insomnia  
Preliminary analyses were calculated to explore the general relationship between 
sleep symptom measures, prior to exploring comorbidity or testing for group differences.  
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Bivariate correlations were used to examine the extent to which the reported sleep apnea 
symptom measure (SSPA), and Insomnia severity measure (ISI) were related (r = .787, p = 
0.001).  These findings suggest that as reported sleep-apnea symptoms increase, so do 
reported Insomnia symptoms. 
Group formation and demographics 
To test further investigate the aims of this study, two groups were formed using the 
results from prevalence analyses, in a manner that has been used in previous OSAHS-
insomnia studies [1].  The groups comprised those with OSAHS-only (n = 64) and those 
with OSAHS-plus-insomnia (OSAHS-plus; n = 41).  A comparison of the demographic 
characteristics of these two groups (OSAHS-only and OSAHS-plus) revealed no 
significant differences on key variables such as length of sleep problem and RDI.   
 
Adverse impacts of insomnia-OSAHS comorbidity 
Mood in OSAHS patients with and without insomnia: Depression, Anxiety, Stress Scale 21 
(DASS-21).  The predictions of this study in relation to mood were that patients in the 
OSAHS plus group would report more increased mood disturbances than the OSAHS-only 
group.  This hypothesis was assessed by comparing the mean total DASS-21 scores 
between the two OSAHS groups.  An independent-samples t test was conducted to 
evaluate the relationship between mood disturbance and the presence of Insomnia in 
OSAHS.  The independent variable, the Insomnia factor, included two levels: OSAHS-
only and OSAHS-plus.  The dependent variable was DASS-21 total scores..  The 
independent-samples t test was significant, t(1, 54.47) = -6.56, p = .001.  The strength of 
the relationship between the two groups and the DASS-21 scores, as assessed by η² = .29, 
was strong, with the Insomnia factor accounting for 33 % of the variance of the dependent 
variable.  As expected, patients in the OSAHS-plus Insomnia group reported significantly 
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more mood disturbance than those patients in the OSAHS-only group (M = 25.88, SD = 
14.34 and M = 9.92, SD = 7.57 respectively).  
To further explore the nature of group differences on the DASS-21, a series of 
independent-samples t-tests was run using the three DASS-21 subscale scores (i.e., 
depression, anxiety, and stress).  The results of these analyses are shown in Table 1.  
DASS-21 subscale analyses revealed significant group differences on all three subscales 
(depression: t(1, 56.72) = -4.90, p = .000, η² = .19; anxiety: t(1, 57.50) = -6.06, p = .000, η² 
= .26; stress: t(1, 56.90) = -6.12, p = .000, η² = .27),  suggesting that participants in the 
OSAHS-plus group experienced more symptoms of depression, anxiety, and stress than 
participants with OSAHS-only. 
 
Insert Table 1 About here 
 
Dysfunctional Beliefs in OSAHS patients with and without insomnia 
 Dysfunctional Beliefs and Attitudes about Sleep Scale (DBAS-10).  The prediction in 
relation to sleep beliefs was that patients in the OSAHS-plus group would report more 
dysfunctional beliefs about sleep than the patients in the OSAHS-only group.  The effect of 
Insomnia on dysfunctional beliefs about sleep was tested in an independent-samples t test.  
The dependent variable was the DBAS-10 total scores with the independent factor 
consisting of two levels: OSAHS-only and OSAHS-plus.  The analysis revealed a  
significance difference in the level of dysfunctional beliefs about sleep between the two 
groups, t(1, 103) = -4.85, p = .000, η² = .19, with patients in the OSAHS-plus group 
reporting more dysfunctional beliefs about sleep than those with OSAHS-only (M = 62.92, 
SD = 18.40 and M = 44.56, SD = 19.27 respectively).  Further exploration of group 
differences using DBAS-10 subscale scores revealed those with OSAHS-plus had 
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significantly more concerns about the long-term consequences of poor sleep on their 
behaviour, t (1, 103) = -4.63, p = .000, η² = .17, and reported higher levels of the need for 
control over their sleep t (1, 103) = -3.29, p = .001, η² = .09, than those without comorbid 
insomnia (OSAHS-plus: M (consequences) = 16.01, SD = 7.22; M (control) = 10.59, SD = 
5.19;  OSAHS-only: M (consequences) = 9.33, SD = 7.21; M (control) = 6.88, SD = 5.90).  
According to Smith and Trinder (2001) a cutoff point for the DBAS that discriminated well 
between young adults with or without Insomnia was a mean VAS score of 35.  Both of the 
OSAHS groups had mean VAS scores greater than 35, suggesting the presence of 
dysfunctional beliefs and attitudes about sleep in both OSAHS-only and OSAHS-plus 
patients at a level that is clinically relevant. 
Habitual Sleep in OSAHS patients with and without Insomnia 
 Finally, the prediction in relation to habitual sleep was that patients in the OSAHS-
plus Insomnia group would report greater disruption in habitual sleep compared to 
OSAHS-only patients.  Measures of habitual sleep were derived from two sources: the 
PghSD (subjective report of habitual sleep parameters) and PSG (objective measure of 
habitual sleep behaviour).  To conduct analyses reliant on data from sleep diaries, 
participants with sleep diary information were selected from the main sample.  Twenty-
seven participants returned completed sleep diaries, including 15 participants from the 
OSAHS-only group and 12 participants with OSAHS-plus.  To conduct analyses reliant on 
PSG data, participants for whom this information could be obtained were selected from the 
main sample.  There were 88 patients with PSG data. 
Habitual Sleep.  In order to compare habitual sleep among those with OSAHS-only and 
OSAHS-plus, measures of sleep latency (SOL-mins), wake after sleep onset (WASO-mins) 
and number of wakes after sleep onset were calculated from sleep diary information.  The 
variables wake after sleep onset (WASO-mins) and sleep onset latency (SOL-mins) were 
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predominately positively skewed.  Analyses with the logarithm transformed variables had a 
significant impact on the results consequently the transformed data was used in all 
subsequent analyses. Group differences on WASO-mins, SOL-mins, and number of wakes 
after sleep-set were assessed via independent-samples t-tests.  The results of these analyses 
are shown in Table 2.  Analyses on the 14 nights of the sleep diary revealed that a 
significant difference existed between the OSAHS-only and OSAHS-plus group on two 
out of three variables (the exception was SOL-mins).  Significant differences were in the 
same direction as previous results reported in this study suggesting that participants in the 
OSAHS-plus group take longer than those without comorbid insomnia to get to sleep and 
wake up more often after falling to sleep.  Results relating to SOL-mins showed a trend in 
this direction, despite non-significance. 
 PSG data was used to compare the groups in terms of total sleep time (hours), total 
time awake (hours) and sleep efficiency (%).  Independent-samples t tests were conducted 
in order to compare the means of the OSAHS-only and OSAHS-plus groups.  The results 
of these analyses are shown in Table 2.  Significant group differences were found on all of 
the PSG-based scores used in this study.  The direction of these group differences was such 
that those with OSAHS-plus had more indicators of poor sleep (worse sleep efficiency, 
more time spent awake, and less total sleep time) than those with OSAHS-only.  Further, 
although significant differences between the OSAHS-only and OSAHS-plus groups were 
found on PSG-based measures, the general pattern of results from these variables suggests 
both groups experienced poor sleep.   
 
Insert Table 2 About here 
 
Discussion 
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 The primary aim of the current study was to examine the prevalence of Insomnia 
symptoms in patients with OSAHS.  A secondary aim of this study was to investigate the 
impact of comorbid OSAHS and insomnia on patient functioning.   Prevalence of Insomnia 
in OSAHS 
 As expected, a significant proportion of OSAHS patients in this study reported at 
least moderate levels of clinical Insomnia, defined according to stringent and conservative 
criteria.  Specifically, 39% of OSAHS patients in this study met the criteria for significant 
Insomnia.  In general, this result is consistent with previous research suggesting a 
significant relationship between OSAHS and Insomnia, with the estimated prevalence of 
insomnia among patients with OSAHS in this study falling between previous estimates of 
OSAHS-insomnia comorbidity in similar samples [1, 7].  The significance of the finding that 
insomnia and OSAHS frequently co-occur can be demonstrated by considering the 
prevalence of insomnia alone in the general population.  According to population estimates 
of insomnia recently reviewed by Ohayon [20] the prevalence of Insomnia is between 9% 
and 15% in the normal population.  The rate of significant insomnia in the current sample 
of OSAHS patients is substantially higher than these population estimates.  Overall these 
findings suggest that persons with suspected OSAHS are at least twice as likely to have 
significant Insomnia as those in the normal population.  In sleep clinic settings the methods 
used to identify comorbid insomnia may need to be revisited to improve detection rates.  
For example, the results of a recent clinical audit undertaken at the study sleep clinic 
showed that less than one percent of the previous 1000 patients attending the clinic 
received a primary or secondary sleep diagnosis of insomnia.   
Adverse impact of comorbidity.    
 Given that Insomnia and OSAHS may co-occur, this raised questions about the 
nature of the relationship between these disorders, as well as other factors that may 
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contribute to sleep disturbance such as mood, habitual sleep, and sleep cognitions.  The 
second aim of this study was to explore the impact of comorbid OSAHS and insomnia on 
these variables.   
A preliminary analysis intended to investigate the relationship between reported 
Insomnia severity and sleep apnea severity was therefore conducted.  The results of 
correlational analyses revealed significant positive relationships between these two 
variables.  That is, as reported Insomnia severity increased, so did reported sleep apnea 
severity.  Thus, it appears that the comorbidity of Insomnia in OSAHS patients is 
associated with increased sleep symptom severity.  It should be noted that it is not possible 
to infer causal links between the variables on the basis of this analysis.  In addition, on the 
basis of these results it is not clear how specific these effects are, with the significant 
associations possibly loading as a more general poor sleep factor.  Nonetheless, in light of 
the finding that Insomnia and OSAHS do co-occur, the pattern of significant positive 
correlations between OSAHS and Insomnia symptoms suggests that Insomnia detection 
strategies should be implemented as part of routine practices in sleep clinics, including 
those that service OSAHS patients predominately.  
In terms of adverse impacts of comorbidity, the general pattern of results expected 
in this study was that patients with OSAHS-plus would report more mood problems 
(depression, anxiety and stress), more habitual sleep problems, and more dysfunctional 
beliefs about sleep than people with OSAHS only.  In general this hypothesis was 
supported, with the exception that a mixed pattern of results in terms of habitual sleep (one 
of the six indices of habitual sleep used in this study did not yield significant group 
differences).  On the majority of measures used in this study however, namely depression, 
stress, anxiety, and most indices habitual sleep, OSAHS patients with comorbid insomnia 
typically reported significantly more impairment than those with OSAHS-only.  The 
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findings in relation to mood suggest that whilst OSAHS-only patients reported were 
“normal” (i.e., endorsed symptom levels of depression, anxiety and stress that placed them 
in the non-clinical range when compared to published normative data for the DASS [16], 
patients in the OSAHS-plus group reported depression, anxiety and stress levels suggestive 
of pathology (i.e., anxiety in the severe range and depression and stress in the moderate 
range).  Thus, the addition of insomnia in OSAHS patients appears to be associated with 
clinical levels of mood disturbance.  Whilst some caution interpreting this finding is 
warranted on the grounds that the DASS is a screening measure only, this finding is 
consistent with previous research [10, 21, 22] that suggests a significant relationship between 
Insomnia and mood disturbance, and should be replicated.  Further, this finding 
underscores the importance of identifying OSAHS patients with comorbid insomnia, given 
they appear to be at increased risk of having mood disorders and may require different 
treatment.   
Findings in relation to dysfunctional sleep beliefs indicated both groups 
experienced a high level of dysfunctional sleep cognition on the DBAS-10 (see [23] for 
information about levels of impairment on the DBAS).  Interestingly, although previous 
studies have indicated a relationship between dysfunctional beliefs and Insomnia [8, 11, 25, 
26], there have been no published studies addressing the presence of dysfunctional beliefs in 
OSAHS patients.  The findings of this study suggest that dysfunctional beliefs are present 
in OSAHS, contrary to the previous notions that these beliefs were only related to 
Insomnia [8, 11].  The implication of this result suggests that dysfunctional beliefs may 
contribute to, or perpetuate, the subjective complaint of OSAHS, or may be a consequence 
of OSAHS.  Although further research is clearly needed to further elucidate the 
relationship between sleep cognition and insomnia and OSAHS, the findings of this study 
suggest there may be a role for targeting these in future OSAHS treatment programs. 
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As stated previously, the findings in relation to habitual sleep were somewhat 
mixed, but generally consistent with predictions that OSAHS-insomnia patients would be 
more impaired on these measures than patients with OSAHS-only.  In this study, two 
indices of habitual sleep were used.  These were based either on sleep diary data 
(subjective estimate of habitual sleep) or PSG data (objective estimate of habitual sleep).  
One of the three indices of habitual sleep (SOL-mins), derived from sleep dairy data 
yielded a non-significant group difference, whilst the other two indices (WASO and time 
awake at night) yielded significant differences consistent with predictions.  That is, data 
from sleep diaries suggested that patients in the OSAHS-plus group had increased WASO, 
and spent more time awake during the night than OSAHS-only patients, but did not take 
significantly longer to fall asleep (although non-significant trends in the data in the 
expected direction were observed).  Nonetheless, it seems reasonable to conclude that 
OSAHS patients who present with comorbid Insomnia typically report different habitual 
sleep patterns than those without comorbid insomnia.    In addition, findings in relation to 
group differences in habitual sleep assessed using PSG suggest that that OSAHS-plus 
patients have significantly worse sleep (i.e., sleep efficiency, total time awake and time 
spent sleeping), than OSAHS patients with insomnia..   
Possible reasons for the mixed pattern of results in relation group differences in 
habitual sleep include methodological factors, such as the way “subjective” information 
about habitual sleep was collected (via patient-completed sleep diary).  Although sleep 
dairies are an accepted method of collecting this type of information and are widely used in 
Insomnia studies [18, 24, 26] future studies using OSAHS and Insomnia patients could include 
patient interviews to improve (or corroborate) sleep diary estimates of habitual sleep 
patterns.   
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 In addition, it is important to note methodological issues associated with the way 
“objective” sleep information was collected in this study, since considerations of these 
issues serves to highlight the robustness of effects observed.  That is, the validity of the 
single night of observation that was used as a basis for PSG comparisons between the 
OSAHS-only and OSAHS-plus groups might be questioned.  PSG had been used in many 
Insomnia studies [27, 28] and is the standard objective measure of sleep.  However, this 
method of collecting sleep information has limitations (see [29]), and as there was only one 
night of overnight sleep measurement this may have decreased the probability of detecting 
disrupted sleep, particularly if insomnia effects were minimized by the first night effect [29].  
Further, although this effect was the same for all patients, the use of the first night data 
may have resulted in underestimation of sleep disturbance in the OSAHS-plus group, as 
there is high night-to-night variability in the sleep of people with [29].   Despite this, as 
indicated above, significant group differences were found on most variables.  Future 
research controlling for first night effects, and using repeated measurement  is suggested 
however, to determine the strength of effects with these additional controls. 
In conclusion, the current study extends on, and provides results consistent with 
previous research into the relationship between Insomnia and OSAHS [1, 7].  Overall, 
greater confidence in the relationship between Insomnia and OSAHS was provided by 1) 
the confirmation of previous findings and 2) some improvement in methodology.   In 
addition, the demonstration of a comorbid relationship between Insomnia and OSAHS in 
approximately one-in-three patients seeking treatment for suspected OSAHS provides a 
framework for many future research possibilities.  The contribution of Insomnia to 
increased OSAHS symptom severity may impact on the effectiveness of CPAP.  For 
example, continued Insomnia symptoms may reduce the perceived benefits of CPAP 
treatment, and reduce compliance (adherence) with treatment.   Future studies are needed 
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to further our understanding of the nature of the relationship between Insomnia and 
OSAHS and its impact on treatments for these conditions. 
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 Table 1.   
Comparison of Means of OSAHS-only and OSAHS-plus Patients and Normative Values of 
the DASS-21. 
      Group                      Subscale                Mean  (SD)                Normative Label 
OSAHS-only  Depression     3.30 (3.23)  Normal 
   Anxiety     2.98 (2.73)  Normal 
   Stress      3.69 (3.42)  Normal 
OSAHS-plus  Depression     8.07 (5.69)  Moderate 
  Anxiety     7.88 (4.69)  Severe 
   Stress      9.98 (5.98)  Moderate 
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Table 2 
Group differences on PghSD- and PSG-based measures of habitual sleep for participants 
with OSAHS-only (N = 29) and OSAHS-plus (N = 28). 
 
 OSAHS-only 
M (SD) 
OSAHS-plus 
M (SD) 
t-value P-value 
PghSD-based measures of habitual sleep (n = 57) 
WASO-mins 13.02 (22.87) 34.34 (51.59) -7.25 .000* 
SOL-mins 16.06 (36.02) 20.54 (34) -1.79 .074 
Number of wakes after sleep onset 13.02 (22.87) 34.34 (51.59) -7.25 .000* 
PSG-based measures of habitual sleep (n = 88) 
Sleep efficiency (%) 70.72 (13.54) 60.17 (22.79) 2.51 .015* 
Time spent awake (hours) 2.01 (.94) 2.81 (2.00) -2.24 .030* 
Total sleep time (hours) 4.79 (1.29) 4.10 (1.69) 2.11 .039* 
 
* Significant group difference 
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